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Abstract
Background: The NS1 protein of influenza A virus is able to bind with many proteins that affect cellular signal
transduction and protein synthesis in infected cells. The NS1 protein consists of approximately 230 amino acids
and the last 4 amino acids of the NS1 C-terminal form a PDZ binding motif. Postsynaptic Density Protein-95
(PSD-95), which is mainly expressed in neurons, has 3 PDZ domains. We hypothesise that NS1 binds to PSD-95,
and this binding is able to affect neuronal function.
Result: We conducted a yeast two-hybrid analysis, GST-pull down assays and co-immunoprecipitations to detect
the interaction between NS1 and PSD-95. The results showed that NS1 of avian influenza virus H5N1 (A/chicken/
Guangdong/1/2005) is able to bind to PSD-95, whereas NS1 of human influenza virus H1N1 (A/Shantou/169/2006)
is unable to do so. The results also revealed that NS1 of H5N1 significantly reduces the production of nitric oxide
(NO) in rat hippocampal neurons.
Conclusion: In summary, our study indicates that NS1 of influenza A virus can bind with neuronal PSD-95, and the
avian H5N1 and human H1N1 influenza A viruses possess distinct binding properties.
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Background
Influenza virus nonstructural protein (NS1) is encoded
by a co-linear mRNA and consists of 202-237 amino
acids, depending on the influenza A virus strains. The
NS1 proteins contain an RNA-binding domain, an effec-
tor domain and an unstructured C-terminal domain
around -20 amino acids long. The last 4 amino acids of
the NS1 C-terminal compose the PDZ binding motif,
which contributes to the virulence of influenza A virus
and modulates viral replication [1]. NS1 plays an impor-
tant role in counteracting the cellular antiviral mechan-
ism mediated by interferon (IFN) [2]. Both the protein
kinase R (PKR) and retinoic acid-inducible gene product
I (RIG I) pathways are suppressed by NS1 [3,4].
Activation of the phosphatidylinositol 3-kinase (PI3K)/
Akt pathway is mediated by NS1 proteins, which are
involved in NF-B, IRF3 and TNF-a production, as well
as apoptosis of cells, such as MDCK, Hela and Vero
cells [5,6].
Postsynaptic density protein 95 (PSD-95) is a major
scaffolding molecule localised at the postsynaptic density
(PSD) of excitatory glutamatergic synapses and is mainly
expressed in neurons of the hippocampus and cortex.
PSD-95, which contains 3 PDZ domains, is a member of
the membrane-associated guanylate kinase (MAGUK)
family. PSD-95 binds with many postsynaptic membrane
proteins, including N-methyl-D-aspartate receptor
(NMDAR), potassium channels, tyrosine kinases and cell
adhesion molecules [7]. Both neuroligins and synaptic
adhesion-like molecule (SALM) are able to interact with
PSD-95 and balance neuronic excitation and inhibition
[8,9]. The recruitment of the a-Amino-3-hydroxy-5-
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the synapse is affected by the expression level of PSD-95
[10]. The ionic equilibrium is mediated by PSD-95, and
can regulate the expression of nitric oxide (NO) [11,12].
Furthermore, PSD-95 is also involved in many diseases,
such as schizophrenia, autism and Fragile X Syndrome
[13].
In our previous study, we found that microglia and
astrocytes of the mouse cortex can be infected by avian
and human influenza viruses in vitro, which result in
the release of different levels of cytokines and NO [14].
It has also been demonstrated that acute encephalitis in
mice is caused by infection with the neurovirulent influ-
enza A virus, which can spread to the amygdale and
hippocampus [15]. There was also difference in viral
replication when mice brains were infected by neuro-
virulent A/WSN/33 (H1N1) and nonneurovirulent A/
Aichi/2/68 (H3N2) [16]. The physiological changes in
neurons caused by direct infection with influenza virus
or cytokines of microglia and astrocytes are unclear.
Using the gene chip technique, it has been predicted
that both avian and human viruses NS1 could bind to
PDZ proteins [1]. Hongbing Liu has also reported that
avian virus NS1 associates with the PDZ proteins Scrib-
ble, Dlg1, MAGI-1, MAGI-2 and MAGI-3, and reduces
apoptosis during infection by disrupting Scribble’sp r o -
apoptosis function [17]. However, it has not been shown
that NS1 can bind to PSD-95, and the resulting neuro-
nal changes are unclear. These results show that NS1 of
the influenza A virus can bind to PSD-95. We also
detected potential differences in binding properties
between the avian influenza virus A/chicken/Guang-
dong/1/2005 (H5N1) and human influenza virus A/
Shantou/169/2006 (H1N1) NS1 proteins. We also mea-
sured the production of NO to investigate the influence
of NS1/PSD-95 binding on signal transduction.
Materials and methods
Animals
This study was preapproved by the Ethical Committee
of Shantou University Medical College and conducted in
conformity with the Experimental Animal Management
Bill issued on 14th November 1988 (Decree NO.2 of
National Science and Technology Commission. China),
and the National Institute of Health Guide for the Care
and Use of Laboratory Animals (NIH Publication
NO.80-23, revised 1996). One to two-day-old specific
pathogen free (SPF) Sprague-Dawley rat were purchased
from Shantou University Medical College Laboratory
Animal Center, Shantou, Guangdong, China.
Cells, viruses, and reagents
Madin-Darby canine kidney (MDCK) cells were cultured
in Dulbecco’s modified Eagle’sm e d i u m( D M E M )
containing antibiotics and 10% fetal calf serum. Primary
neuron cells from rat were isolated and cultured in neu-
robasal medium supplemented with 10% fetal calf
serum, 2% B27, and 1% L-glutamine at 37°C in 5%CO2.
Influenza A viruses A/Shantou/169/06(H1N1) and A/
Chicken/Guangdong/1/05(H5N1) (abbreviated herein as
ST169 and GD05, respectively) were used in this study.
Trizol reagent was purchased from Invitrogen (Carls-
bad, CA, USA). AMV reverse transcriptase and Primer
STAR HS DNA polymerase were purchased from
TaKaRa (Dalian, China). Restriction endonucleases and
T4 DNA ligase were purchased from New England Bio-
labs (NEB, Ipswich, MA, USA).
Mouse anti-NS1 antibody was purchased from Santa
Cruz (Santa Cruz, CA, USA). Rabbit anti-PSD-95 anti-
body was purchased from Cell Signaling (Danvers, MA,
USA). HRP-conjugated goat anti-mouse antibody was
purchased from Sigma (St. Louis, MO, USA). HRP-con-
jugated goat anti-rabbit antibody, Cy3-labeled goat anti-
rabbit antibody, and Alexa Fluor 488-labeled goat anti-
mouse antibody were purchased from Beyotime Biotech-
nology (Jiangsu, China).
Yeast MATCHMAKER GAL4 two-hybrid system 3
and X-a-gal were purchased from Clontech (Palo Alto,
CA, USA); p-Nitrophenyl a-D-galactopyranoside was
purchased from Sigma (St. Louis, MO, USA). TNT T7
Quick Coupled Transcription/Translation Systems,
Transcend Chemiluminescent Non-Radioactive Transla-
tion Detection Systems, and MagneGST pull down sys-
tem were purchased from Promega (Madison, WI,
USA). Protein G magnetic beads were bought from New
E n g l a n dB i o l a b s( N E B ,I p s w i c h ,M A ,U S A ) .W e s tD u r a
enhanced chemiluminescence reagents were purchased
from Pierce (Rockford, IL, USA). A Total Nitric Oxide
Assay kit was purchased from Beyotime Biotechnology
(Jiangsu, China).
Plasmid pGST-PSD-95 harboring the full-length cod-
i n gs e q u e n c eo fr a tP S D - 9 5w a sk i n d l yp r o v i d e db yD r
Bonnie L Firestein (Rutgers University in Piscataway).
NS51-lentivirus was constructed and packaged by Gene-
Chem (Shanghai, China).
Primer design and plasmid construction
Viral RNAs from different influenza A viruses were
extracted using Trizol reagent, and the NS1 coding
sequence was amplified by reverse transcription (RT)-PCR
using the following primers: NS11-S1:5’-AATGGATC-
CATGGATTCCCACACTGT-3’ and NS11-Al: 5’-TC
GGGATCCTCAAACTTCTGACCTAAT-3’ for ST169;
NS51-S1: 5’-TATGGATCCATGGATTCCAACACTG
TG-3’ and NS51-Al: 5’-GACGGATCCTCAAACTTTT-
GACTCAATTG-3’ for GD05. The underlined sequence
indicates the BamHIs i t e so nt h e5 ’end of primers. PCR
products were digested with BamHIa n di n s e r t e di n t o
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tor with N-terminal Flag tag) to yield recombinant plas-
mids pcDNA3-NS11, pcDNA3-NS51, PNF-NS11, and
PNF-NS51. NS11 or NS51 represents the NS1 protein
from H1N1 or H5N1 viruses.
To construct recombinant plasmids for yeast two-
hybrid assay, the following primers were designed:
PSD-S1: 5’-CTGGAATTCATGGACTGTCTCTGTA-
TAGT-3’;P S D - A 1 :5 ’-AATGAATTCTCAGAGTCTC
TCTCGGGC-3’;N S 1 1 - S 2 :5 ’-ACTGAATTCATG-
GATTCCCACACTGTG-3’;N S 5 1 - S 2 :5 ’-TATGGATCC
TTATGGATTCCAACACTGTG-3’. EcoRIo rBamHI
sites on the 5’end of primers are underlined. PCR reac-
tion was performed with plasmid pGST-PSD-95 as a
template using primer sets PSD-S1 and PSD-A1. Reverse
transcription PCR reactions were conducted using pri-
mer sets NS11-S2 and NS11-Al for ST169, and NS51-S2
and NS51-Al for GD05. PCR products were digested
with appropriate enzymes and cloned into pGBKT7 or
pGADT7 vector to generate plasmids pGBK-PSD95,
pGAD-NS11, and pGAD-NS51, respectively.
All of the constructs were verified by sequencing.
Yeast two-hybrid assay
MATCHMAKER GAL4 two-hybrid system 3 was used
for yeast two-hybrid assay according to the manufac-
turer’s protocol. Briefly, to test the possible interactions
between PSD-95 and NS1 proteins from different influ-
enza viruses, AH109 yeast was transformed with plas-
mids pGAD-NS11, pGAD-NS51 or pGADT7 in
combination with pGBK-PSD-95 and plated onto SD/-
Leu/-Trp media (DDO) and SD/-Ade/-His/-Leu/-Trp
media (QDO). AH109 yeast transformed with plasmids
pGBKT7-P53 plus pGADT7-T or pGBKT7-lam plus
pGADT7-T served as a positive and negative control,
respectively. The plates were incubated at 30°C for 3
days. Fresh AH109 colonies grown on DDO agar plates
were picked and streaked on SD/-Ade/-His/-Leu/-Trp
medium containing X-a-gal (QDO/X-a-gal) followed by
incubation at 30°C. The growth and color of the colo-
nies were observed daily for 2 days. In addition, single
AH109 colonies grown on DDO agar plates were trans-
ferred into liquid DDO media and cultured at 30°C with
shaking (250 cycles/min) for 36 hours. The supernatants
were collected via centrifugation at 14,000 g for 2 min
a n du s e df o ra-galactosidase activity analysis following
the manufacturer’s instructions.
GST pull-down analysis
Plasmids pGST-PSD95 or pGEX-5x-1 were transformed
into Escherichia coli BL21. IPTG (isopropyl-b-D-thioga-
lactopyranoside) was added at a final concentration of
0.1 mM at the mid-log phase. After 4 h of induction at
25°C with shaking (200 cycles/min), bacteria pellets
were isolated by centrifugation at 12,000 g for 10 sec.
Pellets were frozen and thawed 2 times, followed by
lysis with MagneGST lysis reagent containing lyticase,
DNase, and protease inhibitors for 40 min. After centri-
fugation at 14,000 g for 10 min, the precipitates were
discarded and the supernatants were mixed with pre-
equilibrated MagneGST beads at 4°C for 30 min. Mag-
netic beads binding GST or GST-PSD-95 were washed
with binding/wash buffer 5 times, and the bound pro-
teins were separated by 8% SDS-PAGE gel and stained
by Coomassie blue.
In vitro transcription/translation of NS11 or NS51 was
performed using plasmids pcDNA3-NS11 or pcDNA3-
NS51 and TNT T7 Quick Coupled Transcription/Trans-
lation Systems, according to the procedure provided by
manufacturer. The translated NS11 and NS51 proteins
were detected by western blot using anti-NS1 antibody.
GST- or GST-PSD-95-binding beads were subse-
quently mixed with NS11 or NS51 proteins at room
temperature for 2 h. After 6 repetitions of extensive
washing with binding/wash buffer containing 300 mM
NaCl, the bound proteins were run on 12% SDS-PAGE
gel and blotted with antibody against NS1.
Co-immunoprecipitation
MDCK cells were transfected with plasmid PNF-PSD-95
or empty vector PNF for 36 h. The cells were then
infected with different influenza A viruses (ST169 or
G D 0 5 )a ta nM O Io f2 .N e g a t i v ec o n t r o lc e l l sw e r en o t
infected. After 8 h, cells were lysed in cold NP-40 lysis
buffer on ice for 50 min and centrifuged at 14,000 g for
10 min. Supernatants were collected and pre-cleared by
protein G magnetic beads for 1 h. Rabbit anti-PSD-95
antibody was added at a dilution of 1:100 for 2 h. Nor-
mal rabbit IgG was used as a control. Protein-antibody
mixtures were further incubated with protein G mag-
netic beads with gentle rotation overnight at 4°C. The
beads were gathered and washed 3 times with NP-40
lysis buffer for 10 min each wash. The precipitated pro-
teins were resolved on 10% SDS-PAGE gel and probed
with the rabbit anti-PSD-95 antibody (1:800) or mouse
anti-NS1 antibody (1:1000) as well as HRP-conjugated
goat anti-rabbit antibody (1:700) or HRP-conjugated
goat anti-mouse antibody (1:2500). In addition, cell
lysates were directly subjected to SDS-PAGE and wes-
tern blotting using indicated antibodies.
Western blotting analysis
Protein extracts were fractionated by 10% SDS-PAGE
gel and transferred onto nitrocellulose membranes. Pro-
teins of interest were detected by incubating with anti-
PSD-95 (1:1000) or anti-NS1 (1:1000) in 5% non-fat
milk-TBST for 4 h at room temperature and blotting
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followed by chemiluminescence detection.
Nitric Oxide Detection
Total Nitric Oxide Assay kit was used for NO detection
according to the manufacturer’sp r o t o c o l .T h eN Ow a s
detected by measuring the nitrite using Griess reagent.
To test the influence of the interaction between PSD-95
and NS1 proteins, the hippocampal neurons were
infected by NS51-lentivirus for 3 days, then treated with
acetylcholine (Ach) at 0.1 μmol/mL. One day later, the
cell lysates were centrifuged, and the NO level of the
supernatant was detected.
Results
Detection of the interaction between NS1 and PSD-95 by
yeast two-hybrid analysis
Firstly, to analyse the interaction of NS1 and PSD-95,
the AH109 strains were transformed by using different
plasmids. The results showed that all AH109 strains
were able to grow in DDO. The strains transformed
with pGAD-NS51 and pGBK-PSD-95 were able to grow
on QDO, whereas the strains transformed with pGAD-
NS11 and pGBK-PSD-95 were unable to grow on QDO
(Figure 1-A). AH109 strains were picked from DDO and
incubated on QDO/X-a-gal. The results showed that
the strains transformed with pGAD-NS51 and pGBK-
PSD-95 turned blue, and the color diffused around the
colonies. Meanwhile, the strains transformed with
pGAD-NS11 and pGBK-PSD-95 turned brown and
showed the cessation of colonies (Figure 1-B). The data
of a-galactosidase activity revealed that AH109 strains
transformed with pGAD-NS51 and pGBK-PSD-95 had a
3-fold increase when compared with the positive con-
trol; the pGAD-NS11 and pGBK-PSD-95 strains looked
similar to the negative control (Figure 1-C).
Interaction of NS51 with PSD-95 in vitro
Next, to detect the interaction of NS1 with PSD-95 in
vitro, GST-PSD-95 or GST was immobilised on mag-
netic protein G beads, and then detected by Coomassie
blue staining (Figure 2-A). Meanwhile, NS11 and NS51
proteins were transcribed and translated in vitro (Figure
2-B). NS11 or NS51 was incubated with GST or GST-
PSD-95 immobilised onto magnetic protein G beads
(Figure 2-C). The results indicated that NS51 was able
to precipitate with PSD-95, whereas NS11 was unable to
bind PSD-95 in vitro.
Interaction of NS51 with PSD-95 in vivo
To further study the interaction between NS1 and PSD-
95 in vivo, co-immunoprecipitation and western blot
assays were performed. If PSD-95 bound to NS1, this
could be established by the resolving the 95 kDa PSD-
95 proteins and the 26 kDa NS1 proteins on an SDS-
PAGE gel. NS51 and PSD-95 were detected by western
blotting (Figure 3-A), whereas no band for NS11 was
detected (Figure 3-B).
Production of NO while NS1 is bound to PSD-95
To analyse the influence of this binding, NO was mea-
sured by enzyme standard instrument. The data revealed
that the production of NO was reduced when hippo-
campal neurons were infected by NS51-lentivirus. Data
r e p r e s e n tt h em e a n±S D .T h er e s u l ts u g g e s t st h a tt h e
binding of NS51 and PSD-95 is able to inhibit the
release of NO induced by Ach (Figure 4).
Discussion
The NS1 protein of influenza A viruses acts as a viru-
lence factor that has multiple accessory functions during
viral infection. The major role of NS1 is its inhibition of
the host immune response, including the IFN, PKR and
RIG 1 pathways. However, it has also been known that
NS1 modulates the viral RNA replication, virus protein
synthesis, and host cell physiology [18]. The PSD-95
protein contains 3 PDZ domains, and the PDZ domains
are bound to many postsynaptic membrane proteins,
including NMDAR, potassium channels, tyrosine kinases
and cell adhesion molecules. Around the NMDAR,
many important proteins exist, such as neuronal nitric
oxide synthase (nNOS), SynGAP and SPAR. As a scaf-
fold protein, PSD-95 plays a very important role in
neurons.
We found that there is an interaction between NS1 of
influenza A virus and PSD-95 of hippocampal neuron,
which has not been previously reported. PDZ domains
are ubiquitous protein interaction modules that recog-
nise a specific C-terminal sequence to assemble protein
complexes in multicellular organisms [19]. The binding
of NS1 to PSD-95 may be through the PDZ domains of
PSD-95 and the PDZ binding motif of the NS51 C-
terminal. Our results also showed that only NS51 is able
to bind with PSD-95. These results were concordant
with the recent reports that avian virus NS1 and human
virus NS1 have distinct binding properties [1]. It has
been demonstrated that the NS1 proteins of H1N1,
H3N2, H5N1, and H7N7 have different RNA silencing
suppression activities, and that the short hairpin
(shRNA) is mainly suppressed by the NS1 of A/WSN/33
(H1N1) [20]. It has also been indicated that NS1 has
interactions with cleavage and polyadenylation specifi-
city factor (CPSF); the NS1 of A/Tx/36/91 (H1N1) and
udorn72 (H3N2) are able to bind with CPSF, whereas
the NS1 of A/PR/8 fails to do so [21,22]. Obenauer et
al. indicated that the distinct binding properties between
avian and human NS1 are due to the differences in the
NS1 C-terminal sequence. The NS1 PDZ binding motif
of avian virus consists of ESEV, and the last 4 amino
acids of human virus NS1 are the RSKV [1]. It was also
reported that the full-length avian virus NS1 protein
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ing proteins using the gene chip technique, whereas the
human virus NS1 protein did not bind as many [1].
In our previous study, we reported that higher levels
of cytokines and inflammatory mediators are released
when astrocytes and microglia are infected by avian flu
virus, but not when they are infected by human flu virus
[14]. The virus infected neurons, and neighbouring
uninfected neurons display apoptotic neurodegeneration,
as shown by the immunohistochemistry [23]. It has
been confirmed that the last 4 amino acids of the NS1
C-terminal are the PDZ binding motif, which modulates
the virulence in different strains of viruses [1,24]. When
the 4 amino acids in the C-terminal are deleted from
NS1, the virus A/WSN/33 (H1N1) is severely attenuated
in tissue culture, and increases in mean lethal dose
(MLD50) compared with wild-type A/WSN/33 [25]. In
addition, the functions of PSD-95 are involved in the
clustering of several neurotransmitter receptors, adhe-
sion molecule ionic channels, cytoskeletal elements, and
signalling molecules at postsynaptic sites [13]. It has
been demonstrated that PSD-95-mediated K
+ channel
clustering is inhibited while PSD-95 function is reduced.
The changes in Ca
2+ are modulated by the NMDAR,
the expression of which is affected by PSD-95, and the
Ca
2+ influx via glutamate-gated calcium channels regu-
lates the formation of nitric oxide [11,12]. Therefore,
N S 5 1m i g h ta f f e c tt h en e u r o n ’s functions through its
interaction with PSD-95 and increase the infectivity of
influenza A virus.
Figure 1 Yeast two-hybrid analysis of the interactions between different NS1 proteins and PSD-95. (A) AH109 yeasts were transformed
with pGBK-PSD-95 plasmid along with pGAD-NS11, pGAD-NS51 or empty vector pGAD-T7 and plated on SD/-Leu/-Trp (DDO) as well as SD/-
Ade/-His/-Leu/-Trp (QDO) agar plates and incubated for 3 days at 30°C. The growth status of AH109 was observed at 72 h. (B) Single AH109
yeast colonies grown on the above DDO plates were picked and transferred to QDO/X-a-gal agar plates and incubated at 30°C for 2 days. The
representative colonies were shown. (C) Different NS1-encoding plasmids were transformed into AH109 yeast together with PGBK-PSD-95
plasmid for a-galactosidase activities assays and grown in DDO liquid culture with PNP-a-gal as substrate. Data were from 3 independent
experiments. pGADT7-T and pGBKT7-p53 plasmids and pGADT7-T and pGBKT7-Lam plasmids were used as positive and negative controls,
respectively.
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we measured the changes of NO in rat hippocampal
neurons, which showed that NO was inhibited when rat
hippocampal neurons were infected by NS51-lentivirus.
Overexpression of PSD-95 in hippocampal neurons
causes the dendritic spines to grow 2-3 times larger
than normal size and increases the amount of nitric
oxide synthase at postsynaptic densities [26]. NO is an
important bioregulatory molecule produced by nNOS in
neurons. It has been reported that NO contributes to
the activation of protein kinase G and the suppression
of caspase activity [27,28]. NO can also induce apoptosis
in the early stage of cells [29]. The binding of NS51 to
PSD-95 leads to the reduction of NO, which might inhi-
bit apoptosis and contribute to the replication of influ-
enza A virus. In addition, as a free radical, NO is
associated with cell aging and death, and is involved in
the oxidative stress reaction in neurons. The reduction
of NO induced by NS51 shows protective effects on
Figure 2 Differential binding of different NS1 proteins with
PSD-95 in vitro. (A) GST or GST-PSD-95 proteins were expressed in
E. coli BL21 and immobilised on magnetic beads. The immobilised
GST or GST-PSD-95 proteins were separated in 8% SDS-PAGE gel
and detected by Coomassie blue staining. M stands for molecular
weight standard. (B) NS11 or NS51 were translated in vitro using
plasmids pcDNA3-NS11 or pcDNA3-NS51 and the TNT T7 Quick
Coupled Transcription/Translation Systems. Expression of NS11 and
NS51 was comfirmed by western blotting using anti-NS1 antibody.
(C) NS11 or NS51 was incubated with GST or GST-PSD-95
immobilised onto magnetic beads. After extensive washing, bound
proteins were dissociated from beads and subjected to western
blotting analysis with anti-NS1 antibody.
Figure 3 Differential interactions of different NS1 proteins with PSD-95 in mammalian cells. MDCK cells were transfected with either PNF-
PSD-95 plasmid or empty vector PNF. At 36 h post-transfection, the cells were infected or not infected with influenza virus GD05 (H5N1) (A) or
ST169 (H1N1) (B) at an MOI of 2 for 8 h. Soluble cellular lysates were immunoprecipitated with rabbit anti-PSD-95 antibody (1:100) or normal
rabbit IgG. The precipitated proteins or total cell lysates (input) were resolved by SDS-PAGE and blotted with antibodies against NS1 or PSD-95.
Non-specific bands are indicated.
Figure 4 Production of NO while NS1 is bound to PSD-95 in
hippocampal neurons. Hippocampal neurons were cultured for 3
days then infected by NS51-lentivirus or the control virus pGC FU-
GFP-LV. At 3 days post-infection, the cells were treated with Ach for
24 h and the release of NO was measured. Data were from 3
independent experiments. Relevant levels of significance are
illustrated in the figure as ** for p < 0.01. NS51-lentivirus and pGC
FU-GFP-LV were used as positive and negative controls, respectively.
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The changes to NO are involved in many diseases, such
as stroke, epilepsy, Alzheimer’s disease, Huntington’s
disease, and Parkinson’s disease [30,31].
Conclusion
In conclusion, we detected differences between avian
and human influenza A virus NS1 binding to PSD-95.
The NS1 of avian virus GD05 is able to bind with PSD-
95, but the NS1 of human virus ST169 is not. Addition-
ally, the release of NO is reduced while NS51 is bound
to PSD-95 in neurons. The interaction of NS1 with
PSD-95 may help explain the mechanism that modulates
the effect of NS1 on the host cell. The reduction of NO
also implies that changes in neuron physiology are
mediated by the binding of NS1 to PSD-95.
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